π₯ Competitor β Amino Tech
US seller at aminotech.shop. ββ₯99% purity peptidesβ¦ for in-vivo laboratory research.β Categories: Peptides Β· Liquids Β· Sprays Β· Aminos Β· Research Oils. Aggressively cheap (BPC-157 $39.99) and broadest gray-area range of the four β sells Trestolone Acetate, DMAA, βCiagraβ/βTadaβ (sildenafil/tadalafil aliases) alongside peptides. 15%-off-next-5-orders email hook. Test-report links on product cards.
Partial capture
Catalog pages are JS-rendered and unreachable from sandbox fetch (homepage only). 16 priced SKUs below; re-capture full list in a browser session. Category floors: Aminos from 34.99 Β· Liquids from 74.99 (floor labels inconsistent with actual prices).
Price list (homepage sample, captured 2026-06-06; ~RM4.03/USD)
| Product | Price (USD) | βRM | Note |
|---|---|---|---|
| BPC157+TB500 βWOLVERINE STACKβ | 69.99 | 282 | same name as our blend |
| BPC-157 | 39.99 | 161 | cheapest of the 4 sites |
| MOTS-C | 54.99 | 222 | |
| Tesamorelin | 49.99β74.99 | 201β302 | |
| HCG | 49.99 | 201 | |
| BAC Water | 9.99 | 40 | |
| Tada (liquid) | 44.99 | 181 | tadalafil alias |
| Ciagra | 79.99 | 322 | sildenafil alias |
| Trestolone Acetate | 59.99 | 242 | hormone β beyond peptides |
| DMAA | 49.99 | 201 | stimulant |
| Thymogen | 69.99 | 282 | bioregulator |
| Cartalax / Ovagen / Vesilute / Vesugen | 64.99 | 262 | bioregulator line |
| B12 + GLP1 S | 124.99 | 504 | combo vial |
Head-to-head vs Indexa (public)
| Product | Indexa | Amino Tech (βRM) | Verdict |
|---|---|---|---|
| Wolverine RM350 | public | RM282 | they undercut ~20% β but itβs their loss-leader bestseller; shipping to MY kills their edge locally |
| BPC-157 solo | not split out | RM161 | reference floor if we ever sell solo BPC |
Takeaways
- βWolverine Stackβ naming is now generic across US sellers β our indexa-product-truth Wolverine name carries no exclusivity; differentiate on COA/Verify + local delivery, not name.
- Bioregulator line (Thymogen, Cartalax, Ovagen, Vesilute, Vesugen at $65) is a category none of our local rivals carry β possible niche expansion candidate.
- They monetise breadth into gray-area compounds. Do not follow β raises platform/regulatory risk that conflicts with our restricted-terms policy; their positioning makes βpeptide-pure, lab-verifiedβ cleaner for us to own.
- Race-to-the-bottom pricing with discount stacking (15% Γ 5 orders) β compete on trust and locality, not price.